Semaglutide War Heats Up: Eli Lilly’s Patrik Jonsson On India Market Shake-Up
Eli Lilly's Exec VP Patrik Jonsson joins CNBC-TV18 to address the intensifying semaglutide competition in India's booming obesity drug market. With the patent expiring soon, generics from Indian firms like Dr Reddy's and Sun Pharma are set to slash prices, shaking up the landscape dominated by Lilly's Mounjaro and Novo's Ozempic/Wegovy. #weightlossdrugs #obesity #pharma #healthcare #ozempic #wegovy #mounjaro #glp1 #indiapharma #healthnews #drugpricing #fitnessindia #wellness #medicalnews #pharmasection #healthupdate #cnbctv18 🔴CNBC TV18 LIVE TV: https://youtube.com/live/P857H4ej-MQ SUBSCRIBE to our Channel: https://bit.ly/3nvEcxf --------------------------------------------------------------------------------------------------------------------- 👑 Check Out Top CNBC TV18 Playlist Videos: 🔹 • Young Turks Reloaded with Shereen Bhan 🔹 • CNBC TV18 Prime | Global Lens 🔹 • World News 2025 | Latest International News 🔹 • CNBC-TV18 Classics 🔹 • OVERDRIVE || CNBC TV18 🔹 • Startup Street ------------------------------------------------------------------------------------ You can also connect with CNBC-TV18 News Online Catch the latest news: https://bit.ly/2YbpXBM Follow CNBC-TV18 round the clock: https://www.cnbctv18.com/live-tv/ Stay updated with all the market action in real time: https://www.cnbctv18.com/market-live/ You can also stay updated with all the latest news on-the-go with CNBC-TV18 Minis: https://www.cnbctv18.com/minis/ Like us on Facebook: / cnbctv18india Follow us on Twitter: / cnbctv18news Follow us on Instagram: / cnbctv18india Catch us on: Linkedin: / cnbc-tv18 n18oc_business About CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. Catch all your favourite shows, exclusive videos, big-ticket interviews and more here.
Ozempic Cheaper in India? Pharma Giants Rush for GLP-1 Market | Semaglutide Goes Off Patent in India
GLP-1 Weight Loss | 10 Things I Wish I Knew Before Starting
A Full-Circle Journey at Stanford: Get to Know ASGCT President Matthew Porteus, PhD
Eli Lilly CEO: How GLP-1s Will Reshape America
10 Things You Should NEVER Do on Retatrutide (ruins it’s benefits)
Silicon Valley's new miracle drug
GUESS THE LANGUAGE: EUROPE EDITION
The New Face of America: Inside the Second Great Depression
Semaglutide Goes Generic in India: Drugs could be as cheap as $14 | Vantage with Palki Sharma | N18G
Retatrutide Dosing Explained (Doctor Breaks Down the Data)
Global Crisis Looms: Will Oil Run Out By July? | Doomberg
Sarah Paine — The war for India (Lecture & interview)
Doctor reveals undisclosed risks of COVID-19 vaccine
I’m a Pathologist: The "Biological Cost" of Ozempic and Mounjaro.
Why Pharmaceuticals Are So Complicated In The U.S. | CNBC Marathon
GLP-1 / Zepbound / Tirzepatide Journey | 6 Month update, the good and the bad!
How great is the threat of war in Europe? Sönke Neitzel in an in-depth interview | DER SPIEGEL
Retatrutide Isn't a Weight Loss Drug — Here's What It Really Does (Weightloss Dr. Explains)
Oura CEO Drops Bombshell on the Future of Health Tech — and It Starts With Your Finger | NYNext
